Publications
- Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial2015 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent2014 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab2013 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reaction2010 | Second Faculty of Medicine
- PRIMARY TESTICULAR LYMPHOMA: A CLINICOPATHOLOGIC MULTICENTRIC STUDY AND DATA FROM REGISTRY OF THE CZECH LYMPHOMA STUDY GROUP (CLSG)2007 | Second Faculty of Medicine
- Diffuse large B-cell lymphomas: heterogeneous origin and prognosis from the view of contemporary diagnostics2003 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Diffuse large B cell lymphomas (DLBCL):analysis of the heterogeneous group by means of immunohistochemistry, PCR and FISHPublication without faculty affiliation
- Diffuse large B cell lymphomas (DLBCL) analysis of the heterogeneous group by means of immunohistochemistry, PCR and FISHPublication without faculty affiliation
- Diffuse large B cell lymphomas in flow cytometry +1Publication without faculty affiliation
- Diffuse large B cell lymphomas: subclassification by means pf clasical and molecular diagnostic methods +1Publication without faculty affiliation
Loading network view...